George E. Katibah, Ph.D. - Publications

Affiliations: 
Microbiology, Molecular Biology and Biochemistry University of California, Berkeley, Berkeley, CA, United States 

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Sivick KE, Desbien AL, Glickman LH, Reiner GL, Corrales L, Surh NH, Hudson TE, Vu UT, Francica BJ, Banda T, Katibah GE, Kanne DB, Leong JJ, Metchette K, Bruml JR, et al. Magnitude of Therapeutic STING Activation Determines CD8 T Cell-Mediated Anti-tumor Immunity. Cell Reports. 29: 785-789. PMID 31618645 DOI: 10.1016/j.celrep.2019.09.089  0.32
2019 Luteijn RD, Zaver SA, Gowen BG, Wyman SK, Garelis NE, Onia L, McWhirter SM, Katibah GE, Corn JE, Woodward JJ, Raulet DH. SLC19A1 transports immunoreactive cyclic dinucleotides. Nature. 573: 434-438. PMID 31511694 DOI: 10.1038/S41586-019-1553-0  0.388
2018 Sivick KE, Desbien AL, Glickman LH, Reiner GL, Corrales L, Surh NH, Hudson TE, Vu UT, Francica BJ, Banda T, Katibah GE, Kanne DB, Leong JJ, Metchette K, Bruml JR, et al. Magnitude of Therapeutic STING Activation Determines CD8 T Cell-Mediated Anti-tumor Immunity. Cell Reports. 25: 3074-3085.e5. PMID 30540940 DOI: 10.1016/J.Celrep.2018.11.047  0.433
2018 Deng W, Lira V, Hudson TE, Lemmens EE, Hanson WG, Flores R, Barajas G, Katibah GE, Desbien AL, Lauer P, Leong ML, Portnoy DA, Dubensky TW. Recombinant promotes tumor rejection by CD8 T cell-dependent remodeling of the tumor microenvironment. Proceedings of the National Academy of Sciences of the United States of America. PMID 30038013 DOI: 10.1073/Pnas.1801910115  0.402
2018 Desbien AL, Gauthier KS, Corrales L, Reiner G, Glickman LH, Katibah G, Hudson TE, Vu U, Surh NH, Francica B, Deng W, Kanne DB, Leong JJ, Ndubaku C, Metchette K, et al. Abstract 631: Intratumoral activation of STING with a synthetic cyclic dinucleotide elicits antitumor CD8 T-cell immunity that effectively combines with checkpoint inhibitors Cancer Research. 78: 631-631. DOI: 10.1158/1538-7445.Am2018-631  0.406
2017 Sivick KE, Surh NH, Desbien AL, Grewal EP, Katibah GE, McWhirter SM, Dubensky TW. Comment on "The Common R71H-G230A-R293Q Human TMEM173 Is a Null Allele". Journal of Immunology (Baltimore, Md. : 1950). 198: 4183-4185. PMID 28533276 DOI: 10.4049/Jimmunol.1700294  0.349
2016 McWhirter SM, Glickman LH, Desbien T, Gauthier KS, Kanne D, Kasibhatla S, Li J, Pferdekamper AC, Katibah G, Lemmens E, Corrales L, Leong M, Ndubaku C, Leong J, Sung L, et al. Abstract B020: STING activation in the tumor microenvironment using a synthetic human STING-activating cyclic dinucleotide induces potent antitumor immunity Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-B020  0.458
2016 Glickman LH, Corrales L, Kanne DB, Kasibhatla S, Li J, Pferdekamper AMC, Gauthier KS, Katibah GE, Leong JJ, Sung L, Metchette K, Deng W, Desbien AL, Ndubaku C, Zheng L, et al. Abstract SY39-02: Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Sy39-02  0.467
2016 Glickman LH, Kanne DB, Kasibhatla S, Li J, Pferdekamper AC, Gauthier KS, Deng W, Desbien AL, Katibah GE, Leong JJ, Sung L, Metchette K, Ndubaku C, Zheng L, Cho C, et al. Abstract 1445: STING activation in the tumor microenvironment with a synthetic human STING-activating cyclic dinucleotide leads to potent anti-tumor immunity Cancer Research. 76: 1445-1445. DOI: 10.1158/1538-7445.Am2016-1445  0.458
2015 Corrales L, Glickman LH, McWhirter SM, Kanne DB, Sivick KE, Katibah GE, Woo SR, Lemmens E, Banda T, Leong JJ, Metchette K, Dubensky TW, Gajewski TF. Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. Cell Reports. 11: 1018-30. PMID 25959818 DOI: 10.1016/J.Celrep.2015.04.031  0.441
2015 Glickman LH, Kanne DB, Gauthier KE, Katibah GE, Leong JJ, Metchette K, Dubensky TW, McWhirter SM. Abstract 4272: Potentin situcancer immunotherapy with synthetic human STING-activating cyclic dinucleotides Cancer Research. 75: 4272-4272. DOI: 10.1158/1538-7445.Am2015-4272  0.467
2014 Katibah GE, Qin Y, Sidote DJ, Yao J, Lambowitz AM, Collins K. Broad and adaptable RNA structure recognition by the human interferon-induced tetratricopeptide repeat protein IFIT5. Proceedings of the National Academy of Sciences of the United States of America. 111: 12025-30. PMID 25092312 DOI: 10.1073/Pnas.1412842111  0.474
2013 Piganeau M, Ghezraoui H, De Cian A, Guittat L, Tomishima M, Perrouault L, René O, Katibah GE, Zhang L, Holmes MC, Doyon Y, Concordet JP, Giovannangeli C, Jasin M, Brunet E. Cancer translocations in human cells induced by zinc finger and TALE nucleases. Genome Research. 23: 1182-93. PMID 23568838 DOI: 10.1101/Gr.147314.112  0.352
2013 Katibah GE, Lee HJ, Huizar JP, Vogan JM, Alber T, Collins K. tRNA binding, structure, and localization of the human interferon-induced protein IFIT5. Molecular Cell. 49: 743-50. PMID 23317505 DOI: 10.1016/J.Molcel.2012.12.015  0.472
2009 Hockemeyer D, Soldner F, Beard C, Gao Q, Mitalipova M, DeKelver RC, Katibah GE, Amora R, Boydston EA, Zeitler B, Meng X, Miller JC, Zhang L, Rebar EJ, Gregory PD, et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nature Biotechnology. 27: 851-7. PMID 19680244 DOI: 10.1038/Nbt.1562  0.321
2008 Doyon Y, McCammon JM, Miller JC, Faraji F, Ngo C, Katibah GE, Amora R, Hocking TD, Zhang L, Rebar EJ, Gregory PD, Urnov FD, Amacher SL. Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nature Biotechnology. 26: 702-8. PMID 18500334 DOI: 10.1038/Nbt1409  0.301
Show low-probability matches.